A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis

Neurology. 2006 Dec 26;67(12):2264; author reply 2264-5. doi: 10.1212/01.wnl.0000252724.67789.1e.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Adolescent
  • Adult
  • Disease-Free Survival
  • Female
  • Humans
  • Interferon beta-1a
  • Interferon beta-1b
  • Interferon-beta / therapeutic use*
  • Male
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Probability
  • Randomized Controlled Trials as Topic

Substances

  • Adjuvants, Immunologic
  • Interferon beta-1b
  • Interferon-beta
  • Interferon beta-1a